Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD, discuss the use of beta-blocker therapy following acute MI ...
HealthDay on MSN1d
Acute Myocardial Infarction Up in People With Epilepsy, 2008 to 2017The prevalence of acute myocardial infarction (AMI) in people with epilepsy increased from 2008 to 2017, according to a study ...
The prevalence of acute myocardial infarction (AMI) in people with epilepsy increased from 2008 to 2017, according to a study ...
Sinai Chicago has received the American Heart Association’s Get With The Guidelines® – Coronary Artery Disease NSTEMI Gold ...
Young patients with myocardial infarction (MI) and fewer traditional risk factors often have greater exposure to urban noise, ...
JPI-289 is under clinical development by Jeil Pharmaceutical and currently in Phase II for Myocardial Infarction.
In a large meta-analysis, complete revascularisation reduced cardiovascular events compared with culprit-only revascularisation in older patients with a myocardial infarction and multivessel disease ...
DAYBREAK was a Phase 3, multi-center, long-term open-label extension study to evaluate the safety and efficacy of Zeposia (ozanimod) administered orally to patients with relapsing forms of multiple ...
The following is a summary of “Angiography-versus wire-based microvascular resistance index to detect coronary microvascular ...
Cardiovascular events are not significantly decreased with edetate disodium chelation in patients with CAD and history of myocardial infarction and diabetes.
Background In acute heart failure (HF), reduced cardiac output, vasoconstriction and congestion may damage the intestinal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback